517 Long-term efficacy of intrathecal interleukin-2 (IT IL2) in metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD). (September 2015) - Glitza, I.C.; Rohlfs, M.L.; Bassett, R.; John, I.; Richard, J.; Iqbal, M.; Bernzen, T.; Gerber, D.L.; Lacey, C.; Diab, A.; Amaria, R.N.; Woodman, S.E.; et al.